Global Cord Blood Corporation (CO) |
| 2.9876 0 (0%) 06-09 09:43 |
| Open: | 2.21 |
| High: | 3.32 |
| Low: | 2.22 |
| Volume: | 0 |
| Market Cap: | 400(M) |
| PE Ratio: | 5.06 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Diagnostics & Research |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 3.88 |
| Resistance 1: | 3.32 |
| Pivot price: | 2.99 |
| Support 1: | 2.63 |
| Support 2: | 2.21 |
| 52w High: | 3.59 |
| 52w Low: | 0.6001 |
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.
| EPS | 0.590 |
| Book Value | 40.140 |
| PEG Ratio | 0.00 |
| Gross Profit | 7.916 |
| Profit Margin (%) | 40.30 |
| Operating Margin (%) | 48.97 |
| Return on Assets (ttm) | 4.6 |
| Return on Equity (ttm) | 11.0 |
Tue, 09 Dec 2025
Stem Cell Banking Market Size, Growth & Analysis, 2033 - Market Data Forecast
Tue, 02 Dec 2025
Comparison of the Top 3 International Cord Blood Banks – FamiCord, CryoHoldco, and GCBC - BioInformant
Thu, 25 Sep 2025
Cord Blood Industry Consolidation Escalates in 2025 - BioInformant
Fri, 05 Sep 2025
Global Trends in Cord Blood and Newborn Stem Cell Banking - BioInformant
Tue, 11 Jun 2024
Global Cord Blood Corporation Investors: Looming Deadline - GlobeNewswire
Mon, 03 Jun 2024
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CO, CORBF - Macau Business
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |